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Background: Health-related quality of life (HRQOL) is an important aspect of diabetes mellitus care. The
objective of the study was to determine the HRQOL of diabetes mellitus (DM) patients in Botswana as lit-
tle known in Africa.Materials and methods: A cross-sectional study of 380 randomly selected DM patients
in a tertiary clinic in Gaborone, Botswana was conducted to obtain Data on HRQOL and structured ques-
tionnaire was used to collect information on sociodemographic and clinical characteristics. Multivariate
logistic regression to determine sociodemographic and clinical characteristics associated. Results:
Majority of patients were female with no formal education or primary level of education. Mean HbA1c
was 7.97% (SD: 2.02) and most patients had poor glycemic control. The majority had both worse physical
composite score (PCS-12) and mental composite score (MCS-12), with worse proportions of the two.
Female gender, older age 65 years, and the presence of three or more documented diabetic complica-
tions were associated with significant worse PCS-12. Presence of two diabetic complications, three or
more diabetic complications, and musculoskeletal disease were associated with significant MCS-12.
Conclusions: Diabetic patients in Botswana have relatively poor HRQOL. The fact that most patients pre-
sent late with complications calls for policy attention to diagnose diabetes mellitus early and prevent
associated complications, ultimately improving health-related quality of life among diabetes mellitus
patients.
 2017 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction According to International Diabetes Federation report of 2015,Diabetes mellitus (DM) is a disease of global public health
importance associated with high morbidity and mortality.1,2about 415 million people have DM globally with the figure pro-
jected to have increased to 642 million by 2040 or maybe even
doubled by the year 2040.3,4 The greatest increase will be in devel-
oping countries (69%) compared with developed countries (20%),5
with non-communicable disease (NCDs) accounting for up to 80%
of deaths among developing countries.6 In Botswana, the preva-
lence of DM among adults (20–79 years) is approximately 52 per
1000 people out of which 31.6 per 1000 remain undiagnosed.3
Health-related quality of life (HRQOL) refers to the physical,
psychological and social aspects of health that are influenced by
person’s experience on beliefs, expectations and perceptions.
Understanding these domains by health care workers has an
2 G.M. Rwegerera et al. / Alexandria Journal of Medicine xxx (2017) xxx–xxxadvantage in terms of incorporating chronic disease management
strategies into routine care, leading to a reduction of both morbid-
ity and mortality, including patients in developing countries.7–12
The psychosocial burden of living with diabetes mellitus is consid-
erable as it affects self-care behaviors, leading to long term poor
glycemic control, increased risk of long-term complications and
poor quality of life.9,13–15 Understanding the measurements of
HRQOL as well as the factors associated with poor quality of life
has a benefit in terms of improving the physical and psychosocial
burden associated with DM, ultimately reducing associated costs,
morbidity and mortality.15,16
Published studies have found that DM patients without compli-
cations have higher overall utility values than those with complica-
tions.17 Currently, most of the published literature on HRQOL of
patients with DM is based on developed countries with little
known among developing countries. Whilst it is well acknowl-
edged that there is better access to health in developed countries
compared to developing countries, there are more associated mor-
bidities of DM in developing countries,9 which will have a consid-
erable impact on their HRQOL.12,18 Consequently, we sought to
determine the HRQOL, and associated sociodemographic and clin-
ical variables, among patients with DM in Botswana. The findings
will be used to suggest future strategies in Botswana to improve
the management of these patients if pertinent. The findings may
also be of interest to other African countries with increasing rates
of NCDs including diabetes.2. Methods
2.1. Study area, design and participants recruitment
Details of study area, design and participants recruitment,
inclusion and exclusion criteria and how sociodemographic and
clinical data was collected have been described in details else-
where,19 In summary, a cross-sectional study was conducted
whereby 380 patients were randomly selected for the purpose of
this study between July to September 2015 in Block 6 clinic, a ter-
tiary unit in Gaborone, Botswana, and data was obtained by means
of standard structured questionnaire interviews, Further data was
obtained from patients’ hospital charts. This clinic was chosen as it
offers services to over 3000 diabetic patients. In Botswana, medici-
nes are provided free-of-charge to patients; consequently, co-
payment for medicines is not an issue.19 On average 1800 to
2000 diabetic patients visit the clinic monthly.2.2. Sample size
The sample size was calculated from the formula of descriptive
cross-sectional study, i.e. N = Z2 p (100  p)/d2; where: N = esti-
mated minimum sample size, Z = Standard deviation of 1.96 at
95% confidence interval, p = Response rate to the SF-12 quality of
life questionnaire in the outpatient clinic20 which was 44.3%, and
d = the margin of error on p, which is approximately 0.05. Conse-
quently, N = 1.96  1.96  44.3  55.7/25, = 379.
As seen, the estimated minimum sample size was 379 patients.2.3. Study instrument
The most widely used generic measure of quality of life in stud-
ies of people with diabetes mellitus is the Medical Outcomes Study
(MOS) Short-Form General Health Survey, which has several forms
(SF-36, SF-20, and SF-12). The MOS instrument includes physical,
social and role functioning scales to capture behavioral dysfunc-Please cite this article in press as: Rwegerera G.M., et al.. Alex J Med (2017), htion, and this instrument has been shown to reflect more subjec-
tively components of health and well-being.21
We chose to use Social factor (SF-12) as a tool to measure health
related quality of life because it has been shown to be as effective
as SF-36. The tool (SF-12), is brief and convenient to use.22–27
Whilst we did not find studies using SF-12 scores among patients
with diabetes mellitus in Botswana, SF-12 has been used several
times to assess HRQOL among patients with chronic diseases in
the Republic of South Africa.28–30 Consequently, in view of the
proximity of two countries and both have public healthcare sys-
tems, we saw it as justifiable to select this tool for our study. Both
countries also have a high prevalence of Human Immunodeficiency
Virus (HIV). In Botswana, over 22% of the adult population have
HIV, with higher rates especially among women.31 Consequently,
considerable opportunity for co-morbidity of diabetes among these
patients.
Specifically, we used the short form of the widely used SF-36
called SF-12v2TM Health Survey (SF-12; Quality Metric Inc., Lincoln,
RI, USA). The SF-12v2TM is a brief and reliable measure of overall
health status.32 It measures eight domains of health; physical func-
tioning, role limitations because of physical health (role-physical),
bodily pain, general health perceptions, vitality, social functioning,
role limitations because of emotional problems (role-emotional)
and mental health.32 The information is then scored by the scale
from 0 to 100 on each of the domains, as well as for the Physical
Component Summary (PCS-12) scale and Mental Component
Summary (MCS-12).33 We entered the responses of SF-12 for each
patient into the SF website (www.sf-36.org/SF-12.html). The
website computes the scores of PCS-12 and MCS-12 into the range
0–100, whereby 0 indicates the lowest composite score and 100
the highest composite score. The outcome variables in our study
were; the worse physical composite score and worse mental com-
posite score.
We did not conduct separate analysis for Type 1 or Type 2 dia-
betes, similar to other studies,12 as the vast majority of patients in
Botswana attending clinics such as this one are Type 2. The major-
ity of Type 1 patients in Botswana continue to attend pediatric and
adolescent clinics at the National hospital. Consequently, it was
perceived that undertaking a separate analysis for the two types
of diabetes would be difficult to interpret; consequently, we com-
bined these two types of diabetes mellitus for the study. However,
we did assess the two types of diabetes as an independent variable.2.4. Dependent variables
We measured both the worse PCS-12 and worse MCS-12 as a
score of <50%, and the better PCS and MCS as the scores of 50%.
Our outcome (dependent) variables were worse PCS-12 and worse
MCS-12.
The choice of 50% cut off is based on the fact that the scores that
are summarized above or equal to 50% are categorized as better
health status and those below 50% are categorized to have a worse
health status.34–372.5. Independent variables
Our independent sociodemographic variables were; age, gen-
der, marital status and level of education. We also measured
weight and height to determine the Body Mass Index (BMI). Glyce-
mic control was determined by extracting results of within past
three months of HbA1c from Integrated Patients Management Sys-
tem (IPMS) and defined as good (<7%) and poor (7%).
We also calculated the average blood pressure in the last 3 vis-
its, and documented the HIV status as recorded either in thettp://dx.doi.org/10.1016/j.ajme.2017.05.010
Table 1
Socio-demographic and clinical characteristics of study participants.
Variable Frequency (%)
Gender
Male 116 (30.5%)
Female 264 (69.5%)
Age
Up to 54 159 (41.8%)
55–64 106 (27.9%)
65 years and more 115 (30.3%)
Level of education
No formal education 70 (18.4%)
Any primary school 181 (47.6%)
Secondary and above 129 (33.9%)
Marital status
Never married 102 (26.8%)
Currently married 157 (41.3%)
Others 121 (31.8%)
Body Mass Index
None obese ( < 30 kg/m2) 168 (50.0%)
Obese (  30 kg/m2) 168 (50.0%)
Duration of diabetes (years)
< 5 178 (49.2%)
5–10 91 (25.1%)
> 10 93 (25.7%)
Type of diabetes
Type 1 23 (6.1%)
Type 2 357 (93.9%)
Modality of treatment
Diet 4 (1.1%)
Oral hypoglycemic agents (OHA) 224 (58.9%)
Insulin 51 (13.4%)
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variables included the duration of suffering from diabetes, type
of diabetes, the regimen used to treat the diabetes, presence or
absence of documented diabetic complications and presence or
absence of documented musculoskeletal disease. For the purpose
of this study, musculoskeletal disease was categorized as diseases
of the muscle, bone or joints associated with pain, stiffness and
limited mobility and involving or affecting gait, arms, legs and
spine (GALS).38,39
2.6. Data analysis
We used the SPSS version 22 statistical software for the analysis
calculated the inferential statistics for proportions of worse out-
comes for both sociodemographic and clinical characteristics. A
multivariate logistic regression analysis was undertaken to deter-
mine the association of worse composite scores (PCS or MCS) and
the factors which were found to be statistically significant in the
bivariate analysis. A p-value of less than 0.05 was considered sta-
tistically significant.
2.7. Ethical clearance
The permission to conduct the study was obtained from the
University of Botswana Ethics Committee and the Institutional
Review Board (IRB) and Ethics Committee at Princess Marina
Hospital. Ethical clearance was secured from the Botswana Min-
istry of Health Research Unit and all the patients signed informed
consent.Both OHA and Insulin 101 (26.6%)
Glycemic control (HbA1C)
Normal ( < 7%) 147 (39.9%)
Poor (  7%) 221 (60.1%)
Presence of DM complications
Yes 311 (81.8%)
No 69 (18.2%)
HIV status within past 1 year
Positive 38 (10.0%)
Negative 235 (61.8%)
Don’t know 107 (28.2%)
CD4 (only for HIV positive)a
Up to 500 12 (36.4%)
Over 500 21 (63.6%)
Average Blood Pressure (mmHg)
<140/90 162 (42.6%)
140/90 218 (57.4%)3. Results
3.1. Sociodemographic and clinical characteristics of study participants
Details of sociodemographic characteristics and clinical charac-
teristics of the study population have been described elsewhere.19
In this study, four more patients who were on diet were included in
the analysis making a total of 380 patients. The majority were
female with no formal education or primary level of education
(Table 1).
The mean HbA1c of participants was 7.97% (SD: 2.02) and 60.1%
of patients had poor glycemic control (HbA1c  7%). Among the
HIV positive patients, 63.6% had CD4 counts above 500 lmol/l
and mean CD4 of 641.58 (SD: 302.20). The majority of study partic-
ipants (57.4%) had uncontrolled hypertension (Table 1).Presence of musculoskeletal disease
Yes 62 (16.4%)
No 316 (83.6%)
a Missing 5 CD4 values.
Table 2
Overall health related quality of life.
Variable Frequency (%) Mean ± SD (Range)3.2. Health-related quality of life of study participants
The majority of study participants had both worse physical
composite score (PCS-12) and mental composite score (MCS-12);
with worse proportions of the two accounting for 59.7% and
55.3% respectively. Likewise, the overall mean scores for both
PCS-12 and MCS-12 were below 50% (Table 2).Physical Composite score (PCS-12) 44.39 ± 10.67 (16.2–63.7)
Below average (<50%) 227 (59.7%)
Above average (50%) 153 (40.3%)
Mental Composite score (MCS-12) 45.96 ± 10.57 (17.4–63.4)
Below average (<50%) 210 (55.3%)
Above average (50%) 170 (44.7%)3.3. Association between health-related quality of life and
sociodemographic and clinical characteristics
Results of descriptive sociodemographic and clinical groups for
PCS-12 and MCS-12 are shown in Table 3. Factors associated with
significant worse PCS-12 in the bivariate analysis were female gen-
der, older age, primary or no formal education, being married/div
orced/widowed/separated, type of DM, duration of DM, presence
of DM complications, uncontrolled hypertension and presence doc-Please cite this article in press as: Rwegerera G.M., et al.. Alex J Med (2017), humented musculoskeletal disease. On the other hand; Body Mass
Index (BMI), modality of treatment, glycemic control and HIV sta-
tus were not associated with PCS-12.ttp://dx.doi.org/10.1016/j.ajme.2017.05.010
Table 3
Association of health related quality of life and sociodemographic and clinical variables.
Variables PCS < 50% PCS  50% P-value MCS < 50% MCS  50% P-value
Gender 0.000 0.041
Male 53 (45.7%) 63 (54.3%) 55 (45.4%) 61 (52.6%)
Female 174 (65.9%) 90 (34.1%) 155 (58.7%) 109 (41.3%)
Age 0.000 0.000
Up to 54 66 (41.5%) 93 (58.5%) 75 (47.2%) 84 (52.8%)
55–64 71 (67.0%) 35 (33.0%) 52 (49.1%) 54 (50.9%)
65 years and more 90 (78.3%) 25 (21.7%) 83 (72.2%) 32 (27.8%)
Level of education 0.000 0.001
No formal education 55 (78.6%) 15 (21.4%) 46 (65.7%) 24 (34.3%)
Any primary school 115 (63.5%) 66 (36.5%) 109 (60.2%) 72 (39.8%)
Secondary and above 57 (44.2%) 72 (55.8%) 55 (42.6%) 74 (57.4%)
Marital status 0.000 0.000
Never married 44 (43.1%) 58 (56.9%) 42 (41.2%) 60 (58.8%)
Currently married 100 (63.7%) 57 (36.3%) 86 (54.8%) 71 (45.2%)
Others 83 (68.6%) 38 (31.4%) 82 (67.8%) 39 (32.3%)
Body Mass Index 0.374 0.442
None obese (<30 kg/m2) 96 (57.1%) 72 (42.9%) 90 (53.6%) 78 (46.4%)
Obese (30 kg/m2) 104 (61.9%) 64 (38.1%) 97 (57.7%) 71 (42.3%)
Duration of diabetes (years) 0.003 0.053
<5 90 (50.6%) 88 (49.4%) 93 (52.2%) 85 (47.8%)
5–10 55 (60.4% 36 (39.6%) 45 (49.5%) 46 (50.5%)
>10 67 (72.0%) 26 (28.0%) 61 (65.6%) 32 (34.4%)
Type of diabetes 0.000 10 (43.5%) 13 (56.5%) 0.241
Type 1 4 (17.4%) 19 (82.6%)
Type 2 223 (62.5%) 134 (37.5%) 200 (56.0%) 157 (44.0%)
Modality of treatment 0.337 0.719
Oral hypoglycemic agents (OHA) 134 (59.8%) 90 (40.2%) 120 (53.6%) 104 (46.4%)
Insulin 26 (51.0%) 25 (49.0%) 28 (54.9%) 23 (45.1%)
Both OHA and Insulin 64 (63.4%) 37 (36.6%) 59 (58.4%) 42 (41.6%)
Glycemic control (HbA1C) 0.808 0.883
Normal (<7%) 89 (60.5%) 58 (39.5%) 80 (54.4%) 67 (45.6%)
Poor (7%) 131(59.3%) 90 (40.7%) 122 (55.2%) 99 (44.8%)
Presence of DM complications 0.000 0.000
Yes 205 (65.9%) 106 (34.1%) 192 (61.7%) 119 (38.3%)
No 22 (31.9%) 47 (68.1%) 18 (26.1%) 51 (73.9%)
HIV status within past 1 year 0.181 0.044
Positive 18 (47.4%) 20 (52.6%) 15 (39.5%) 23 (60.5%)
Negative 140 (59.6%) 95 (40.4%) 128 (54.5%) 107 (45.5%)
Don’t know 69 (64.5%) 38 (35.5% 67 (62.6%) 40 (37.4%)
Average Blood Pressure (mmHg) 0.028
<140/90 82 (50.6%) 80 (49.4%) 0.002 79 (50.6%) 83 (49.4%)
140/90 145 (66.5%) 73 (33.5%) 131 (66.5%) 87 (33.5%)
Presence of musculoskeletal disease 0.000
Yes 51 (82.3%) 11 (17.7%) 0.000 51 (82.3%) 11 (17.7%)
No 174 (55.1%) 142 (44.9%) 158 (50.0%) 158 (50.0%)
4 G.M. Rwegerera et al. / Alexandria Journal of Medicine xxx (2017) xxx–xxxAs regards MCS-12, the factors associated with significant
worse scores included female gender, older age, being single/divo
rced/separated/widowed, the presence of DM complications, HIV
status, uncontrolled hypertension and the presence of muscu-
loskeletal disease.
Body Mass Index (BMI), duration of DM, modality of treatment
and glycemic control were not associated with MCS-12 in bivariate
analysis (Table 3).3.4. Multivariate logistic regression analysis of factors associated with
worse physical composite score (PCS-12)
Among the sociodemographic and clinical variables studied,
only female gender (p-value = 0.023, AOR = 1.95; 95% CI = 1.09,
3.48), older age  65 years (p-value = 0.015, AOR = 2.43; 95%
CI = 1.18, 4.99). The presence of three or more documented dia-
betic complications (p-value = 0.002, AOR = 3.47; 95% CI = 1.56,
7.71) were associated with significant worse physical composite
scores in multivariate analysis (Table 4).Please cite this article in press as: Rwegerera G.M., et al.. Alex J Med (2017), h3.5. Multivariate logistic regression analysis of factors associated with
worse mental composite score (MCS-12)
In multivariate logistic regression analysis, worse mental health
scores were significantly associated with the presence of two dia-
betic complications (p-value = 0.028, AOR = 2.40; 95% CI = 1.09,
5.26), three or more diabetic complications (p-value = 0.000,
AOR = 5.37; 95% CI = 2.41, 11.96) and the presence of documented
musculoskeletal disease (p-value = 0.020, AOR = 2.52; 95%
CI = 1.15, 5.52).
On the other hand, gender, age, level of education, marital sta-
tus, Body Mass Index, HIV status and modality of treatment were
not associated with significant worse MCS-12 scores in the multi-
variate analysis (Table 5).
3.6. Health-related quality of life association among HIV positive
patients
Results of recent CD4 counts were available for 33/38 (86.8%) of
known HIV positive patients. The association between CD4 levelttp://dx.doi.org/10.1016/j.ajme.2017.05.010
Table 4
Multivariate logistic regression analysis of factors associated with below average PCS-
12.
Variables Adjusted odds ratio
(95% CI)
P-value
Gender
Male Reference
Female 1.95 (1.09, 3.48) 0.023
Age in years
21–54 Reference
55–64 1.67 (0.86, 3.22) 0.127
65 & above 2.43 (1.18, 4.99) 0.015
Level of education
No formal education 2.01 (0.84, 4.84) 0.116
Any primary education 1.10 (0.59, 2.04) 0.747
Secondary and above Reference
Marital status
Never married Reference
Currently married 1.37 (0.70, 2.66) 0.346
Others 1.60 (0.80, 3.20) 0.182
BMI
Non-obese (<30 kg/m2) Reference
Obese (30 kg/m2) 0.97 (0.57, 1.65) 0.917
Type of DM
Type 1 Reference
Type 2 1.38 (0.24–7.78) 0.715
Documented diabetes complications
None Reference
One 1.30 (0.59, 2.86) 0.511
Two 2.14 (0.97, 4.72) 0.058
Three or more 3.47 (1.56, 7.71) 0.002
HIV status
Positive Reference
Negative 0.89 (0.38, 2.06) 0.795
Unknown 0.68 (0.26, 1.74) 0.425
Average BP measurement
Controlled (<140/90 mmHg) Reference
Uncontrolled (140/90 mmHg) 1.14 (0.67, 1.94) 0.617
Type of medication
OHA Reference
Insulin 1.00 (0.42, 2.37) 0.984
Both 1.18 (0.65, 2.13) 0.586
Muskulo-skeletal disease
Yes 1.79 (0.81, 3.93) 0.147
No Reference
Table 5
Multivariate logistic regression analysis of factors associated with below average
MCS-12.
Variables Adjusted odds ratio
(95% CI)
P-value
Gender
Male Reference
Female 1.19 (0.68, 2.11) 0.530
Age in years
21–54 Reference
55–64 0.56 (0.29, 1.08) 0.085
65 & above 1.26 (0.61, 2.58) 0.526
Level of education
No formal education 1.68 (0.72, 3.90) 0.223
Any primary education 1.53 (0.82, 2.85) 0.172
Secondary and above Reference
Marital status
Never married Reference
Currently married 1.01 (0.52, 1.95) 0.969
Others 1.58 (0.79, 3.13) 0.190
BMI
Non-obese (<30 kg/m2) Reference
Obese (30 kg/m2) 1.10 (0.65, 1.85) 0.707
Documented diabetes complications
None Reference
One 1.98 (0.90, 4.38) 0.089
Two 2.40 (1.09, 5.26) 0.028
Three or more 5.37 (2.41, 11.96) 0.000
HIV status
Positive Reference
Negative 1.28 (0.55, 2.97) 0.551
Unknown 1.73 (0.67, 4.43) 0.250
Average BP measurement
Controlled (<140/90 mmHg) Reference
Uncontrolled (140/90 mmHg) 0.92 (0.54, 1.56) 0.776
Type of medication
OHA Reference
Insulin 1.78 (0.77, 4.09) 0.170
Both 1.37 (0.76, 2.47) 0.284
Muskulo-skeletal disease
Yes 2.52(1.15, 5.52) 0.020
No Reference
Table 6
Health related quality of life association with CD4 among HIV positive patients.
CD4 up to 500 (%) CD4 over 500 p-value
PCS-12 1.00
<50% below average 5 (41.7%) 10 (47.6%)
50% above average 7 (58.3%) 11 (52.4%)
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reveal any significance with p-values of 1.00 and 0.46 respectively
(Table 6).MCS-12 0.46
<50% below average 3 (25.0%) 9 (42.9%)
50% above average 9 (75.0%) 12 (57.1%)
Mean CD4 is 641.58 lmol/l.4. Discussion
The overall HRQOL of our study participants was worse than the
average population (Table 2). This is consistent with other studies
researching quality of life among diabetic patients.12,40–43 Most of
the published studies have shown female gender and older age
to be associated with overall worse health-related quality of life
scores.9,16,43–49 These findings are similar to our study for the phys-
ical composite score (PCS-12) where female gender was signifi-
cantly associated with worse scores in the multivariate analysis
(Table 4).
Older age was associated with worse PCS-12 and MCS-12 in the
bivariate analysis (Table 3); however, during multivariate analysis
only worse physical composite score was associated older age in
our study (Tables 4 and 5), which is similar to findings found else-
where9,50 Marital status has also been shown to influence HRQOL
in previous studies. According to Jacobson et al.51, it has beenPlease cite this article in press as: Rwegerera G.M., et al.. Alex J Med (2017), hshown that single and married people had better quality of life
than those who were divorced/separated. However, a study in
Greece found contrasting results with being single associated with
worse HRQOL.52 In our study, we found that being single was asso-
ciated with better quality of life both for PCS-12 and MCS-12 dur-
ing bivariate analysis (Table 3); however, marital status had no
influence on quality of life during multivariate analysis (Tables 4
and 5).
Previous studies have shown inconsistent findings of the dura-
tion of DM on quality of life, with some studies showing that long
duration is associated with decreased quality of life16,47,53,54 whilst
others showed no association.12,55,56 Our study also found nottp://dx.doi.org/10.1016/j.ajme.2017.05.010
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andMCS-12 (Tables 4 and 5). The lack of association between dura-
tion of DM and quality of life in this study is rather surprising con-
sidering the fact that older age, which was significantly associated
with worse PCS-12 in our study (Table 4), is presumably associated
with a longer duration of DM. This lack of association could be due
to the fact that our study cohort consisted mostly of patients diag-
nosed recently (shorter duration of DM) with complications.
Our study also showed that a lower level of education, namely
no formal education and primary education, were associated with
worse HRQOL outcomes for both PCS-12 and MCS-12 in bivariate
analysis (Table 3); which is similar to previous studies.16,57 How-
ever, the findings in multivariate analysis were not significant
(Tables 4 and 5).
Higher Body mass index (BMI) has been shown to be associated
with a higher number of chronic and somatic illnesses and subse-
quently decreased physical health-related quality of life.56 Most of
the previous studies have consistently shown that increased BMI is
associated negatively with both PCS-1220,36,58–63 and MCS-
12.20,59,62–65 Our study cohort consisted of over 75% of patients
who were either overweight or obese; however, we did not find
any association between HRQOL (both PCS-12 and MCS-12) and
body mass index (Table 3). This lack of association is similar to pre-
vious studies.9,66,67 One possible reasons may be that overweight
and obesity are linked to multifactorial aetiologies such as genetic,
metabolic, behavioral, social and cultural issues and the SF-12
instrument may not be the most sensitive instrument to determine
any association between HRQOL and BMI.68,69
The results of previous studies comparing HRQOL and modali-
ties of treatment have produced contrasting results. In studies
involving both patients with Type 1 and Type 2 DM; the use of
insulin injections was associated with worse quality of
life.20,36,49,68 and patients on combination of oral hypoglycemic
agents (OHA) and insulin had better quality of life than those on
insulin alone in a study of type 2 DM patients.57 Our study though
did not find any association between the modality of treatment
and HRQOL. One of the possible reason may be that patients with
Type 1 and 2 diabetes have different expressions in their quality of
life and our study only had a limited number 23/380 (6.1%) of
patients with Type 1 DM which may not be sufficient to detect
any changes. Another study with large sample size of Type 1 DM
is necessary to provide more conclusive results in this aspect.
Clinically, it can be extrapolated that for diabetes mellitus
patients poor glycemic control will be associated with both
increased prevalence and incidence of macrovascular and
microvascular complications, ultimately leading decreased
HRQOL.58,70–72 However, studies have produced contrasting
results, with some showing poor glycemic control to be associated
with worse HRQOL47,54,73 whilst others found no association.74–77
Our study did not find an association between glycemic control
and HRQOL.
Previous studies consistently showed that quality of life is neg-
atively associated increased number of diabetes mellitus complica-
tions.16,36,52,57,74,78,79 Our study also revealed similar findings with
number of DM complications significantly associated with both
worse PCS-12 and MCS-12 (Table 3).
Diabetes mellitus is associated with variety of musculoskeletal
diseases; the latter being correlated with longer duration of DM
and poor metabolic control. Musculoskeletal diseases in DM have
been previously associated worse HRQOL.39,80,81 We sought to find
an association between documented musculoskeletal diseases and
HRQOL among our study participants. However, whilst we
expected that patients with musculoskeletal disease to have worse
PCS-12, this was not seen. The presence of documented muscu-
loskeletal disease was though significantly associated with worse
mental composite scores (Table 5). This needs further investigationPlease cite this article in press as: Rwegerera G.M., et al.. Alex J Med (2017), hto determine how musculosketal disease actual impacts on the
quality of life of these patients.
Diabetes mellitus and HIV disease are both chronic conditions
associated with worse HRQOL in terms of physical and mental
health status.82,83 As for HIV, lower CD4 is associated with oppor-
tunistic infections and higher morbidity and mortality.83 Conse-
quently, it was expected that DM patients with coexisting HIV
disease would have depicted worse HRQOL outcomes. However,
we found no association between HIV status and HRQOL regardless
of CD4 levels (Table 6). Previous studies have shown that being on
Antiretroviral treatment (ART) regardless of immunosuppression
status results in improved health-related quality of life scores.84,85
Whilst it was not the intention of this study to determine ART sta-
tus, all the HIV positive patients in our study were on ART, and
their CD4 counts were high (mean CD4 = 641.58 lmol/l) – Table 1;
hence less likelihood of associated HIV conditions. There is a need
to carry further studies among large cohort of DM patients who are
HIV positive to verify our findings. This is particularly important
given the extra pill burden with these patients, and potential addi-
tional impact on adherence.
5. Study limitations
The results of this study are very important; however they need
to be interpreted on the background of several limitations. Firstly,
our study being a cross-sectional study in design; it only provides
association and not causation. Secondly, though we analyzed both
sociodemographic and clinical variables, including complications
and musculoskeletal disease, we did not assess health behavioral
factors such as diabetes-self management, alcohol drinking and
smoking. These variables might also have had an impact on multi-
variate analysis. Thirdly, our clinic being a tertiary clinic may be
presumed to have patients with more complications and subse-
quent worse quality of life outcomes; however, it should be clear
that the clinic serves in the capacities of primary, secondary and
tertiary care making results representative of diabetic patients in
Botswana. Consequently despite these limitations, we believe our
findings are robust providing direction for the future to improve
the care of these patients.
6. Conclusions
The study findings indicate that diabetic patients in Botswana
have relatively poor HQOL affecting both physical and mental-
well-being. Female gender and older age was associated with
worse physical composite scores. Musculoskeletal disease was
associated with worse mental composite scores. On the other hand,
increased number of diabetic complications was associated with
worse scores for both physical and mental composite scores. The
fact that most patients present late with complications calls for
attention to set policies that help diagnose diabetes mellitus earlier
and prevent associated complications, ultimately improving
health-related quality of life among diabetes mellitus patients. This
potentially includes programmes around self-management as well
medication adherence if this proves to be a problem. These are
subject areas for the future.
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